Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations

Библиографические подробности
Главные авторы:	Pellagatti, A, Steeples, V, Sharma, E, Repapi, E, Yip, B, Armstrong, R, Dolatshad, H, Lockstone, H, Taylor, S, Giagounidis, A, Vyas, P, Papaemmanuil, E, Woll, P, Killick, S, Malcovati, L, Hellstrom-Lindberg, E, Cazzola, M, Smith, C, Boultwood, J
Формат:	Conference item
Опубликовано:	Elsevier 2017

Схожие документы

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.
по: Yip, B, и др.
Опубликовано: (2017)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
по: Boultwood, J, и др.
Опубликовано: (2014)

Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations
по: Pellagatti, A, и др.
Опубликовано: (2018)

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
по: Armstrong, R, и др.
Опубликовано: (2017)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
по: Pellagatti, A, и др.
Опубликовано: (2014)

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1 mutant myelodysplastic syndromes
по: Dolatshad, H, и др.
Опубликовано: (2016)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
по: Pellagatti, A, и др.
Опубликовано: (2010)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
по: Pellagatti, A, и др.
Опубликовано: (2011)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
по: Pellagatti, A, и др.
Опубликовано: (2011)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
по: Pellagatti, A, и др.
Опубликовано: (2009)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
по: Pellagatti, A, и др.
Опубликовано: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
по: Pellagatti, A, и др.
Опубликовано: (2010)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
по: Pellagatti, A, и др.
Опубликовано: (2010)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
по: Pellagatti, A, и др.
Опубликовано: (2008)

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
по: Pellagatti, A, и др.
Опубликовано: (2016)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
по: Boultwood, J, и др.
Опубликовано: (2009)

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
по: Pellagatti, A, и др.
Опубликовано: (2009)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes
по: Pellagatti, A, и др.
Опубликовано: (2007)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
по: Pellagatti, A, и др.
Опубликовано: (2005)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
по: Pellagatti, A, и др.
Опубликовано: (2013)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
по: Boultwood, J, и др.
Опубликовано: (2010)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: Involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
по: Pellagatti, A, и др.
Опубликовано: (2006)

Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arrays
по: Wang, L, и др.
Опубликовано: (2007)

Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
по: Yusuke Shiozawa, и др.
Опубликовано: (2018-09-01)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes (British Journal of Haematology (2008) 142, (57-64))
по: Pellagatti, A, и др.
Опубликовано: (2009)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
по: Pellagatti, A, и др.
Опубликовано: (2008)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
по: Boultwood, J, и др.
Опубликовано: (2007)

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
по: Pellagatti, A, и др.
Опубликовано: (2006)

High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic
по: Papaemmanuil, E, и др.
Опубликовано: (2012)

Somatic Mutation of SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts
по: Malcovati, L, и др.
Опубликовано: (2011)

Myelodysplastic/myeloproliferative disorders
по: Luca Malcovati, и др.
Опубликовано: (2008-01-01)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia
по: Pellagatti, A, и др.
Опубликовано: (2014)

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia.
по: Pellagatti, A, и др.
Опубликовано: (2014)

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
по: Koji Kitamura, и др.
Опубликовано: (2021-04-01)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
по: Malcovati, L, и др.
Опубликовано: (2011)

Discovering transcription and splicing networks in myelodysplastic syndromes.
по: Hongyan Wang, и др.
Опубликовано: (2013-01-01)

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.
по: Dimitriou, M, и др.
Опубликовано: (2016)

L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients
по: Bello, E, и др.
Опубликовано: (2018)

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts
по: Boultwood, J, и др.
Опубликовано: (2008)

Aberrant splicing and drug resistance in AML
по: Rosalia de Necochea-Campion, и др.
Опубликовано: (2016-09-01)